granisetron has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brygger, L; Herrstedt, J | 1 |
| Carmichael, J; Harris, AL | 1 |
1 review(s) available for granisetron and Cardiovascular Diseases
| Article | Year |
|---|---|
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.
Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2014 |
1 trial(s) available for granisetron and Cardiovascular Diseases
| Article | Year |
|---|---|
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Agents; Area Under Curve; Cardiovascular Diseases; Electrocardiography; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2004 |